S&S Healthcare Holding Ltd. (TPEX:4198)
36.80
-2.20 (-5.64%)
Apr 29, 2026, 1:21 PM CST
S&S Healthcare Holding Revenue
In the year 2025, S&S Healthcare Holding had annual revenue of 204.21M TWD, down -15.00%. S&S Healthcare Holding had revenue of 55.72M in the quarter ending December 31, 2025, a decrease of -2.50%.
Revenue
204.21M
Revenue Growth
-15.00%
P/S Ratio
4.60
Revenue / Employee
n/a
Employees
n/a
Market Cap
940.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 204.21M | -36.04M | -15.00% |
| Dec 31, 2024 | 240.25M | -14.28M | -5.61% |
| Dec 31, 2023 | 254.52M | 86.00K | 0.03% |
| Dec 31, 2022 | 254.44M | 132.08M | 107.95% |
| Dec 31, 2021 | 122.35M | 20.99M | 20.71% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Radiant Innovation | 387.58M |
| Wiltrom | 311.77M |
| PlexBio | 127.10M |
| AmCad BioMed | 30.44M |
| AViTA | 936.39M |
| Rossmax International | 3.80B |
| Diamond Biotechnology | 698.11M |
| Cowealth Medical Holding | 2.96B |